Mark Rivard
机构: Professor of Radiation Oncology, Brown University
每年引用次数
引用次数
引用: 10,107
H-指数: 48
I10-指数 : 111
出版物: 476
Neutron dosimetry, moderated energy spectrum, and neutron capture therapy for californium-252 medical sources
Mark Joseph Rivard
PhDT 6370
7
1998
Neutron dosimetry, moderated energy spectrum, and neutron capture therapy for ²⁵ {45} R²Cf medical sources
Mark Joseph Rivard
1998
The relative biological effectiveness of high dose rate Cf-252 neutrons: a parameter-based radiobiological model
L.J Stapleford , M.J Rivard , A Mahajan , D.E Wazer
International Journal of Radiation Oncology*Biology*Physics 54 ( 2) 226 -227
1
2002
Selective perturbation of in vivo linear energy transfer using high-Z vaginal applicators for Cf-252 brachytherapy
M.J Rivard , K.E Evans , L.C Leal , B.L Kirk
Nuclear Instruments & Methods in Physics Research Section B-beam Interactions With Materials and Atoms 213 621 -625
1
2004
A position-sensitive neutron spectrometer/dosimeter based on pressurized superheated drop (bubble) detectors
Francesco d’Errico , R Nath , SK Holland , M Lamba
Nuclear Instruments & Methods in Physics Research Section A-accelerators Spectrometers Detectors and Associated Equipment 476 ( 1) 113 -118
12
2002
Update of the AAPM task group no. 43 report - a revised AAPM protocol for brachytherapy dose calculations
Mark J Rivard , Bert M Coursey , Larry A DeWerd , William F Hanson
International Journal of Radiation Oncology Biology Physics 57 ( 2)
8
2003
Evaluation of the NCI IMRT benchmark for clinical trials
MJ Engler , MJ Rivard ,
International Journal of Radiation Oncology Biology Physics 57 ( 2)
2
2003
A discretized approach to determining TG-43 brachytherapy dosimetry parameters: case study using Monte Carlo calculations for the MED3633 103Pd source.
M.J Rivard
Applied Radiation and Isotopes 55 ( 6) 775 -782
33
2001
WE‐A‐BRB‐08: Comparison of Brachytherapy Dose Distribution Using the Gamma‐Index Method
Y Yang , M J Rivard
Medical Physics 38 ( 6) 3793 -3793
2011
SU‐FF‐T‐67: A TG43 Methodology to Describe Iridium‐Wires with Variable Length
F Van den Heuvel , M De Brabandere , E Van Limbergen , M J Rivard
Medical Physics 33 ( 6) 2064 -2064
1
2006
DA BRADLEY
J CSIKAI , S JUDGE , FF KNAPP , P MITCHELL
2004
DA BRADLEY
BM COURSEY , J CSIKAI , WL DUNN , A HARMS
2005
Testes dose following implantation using I-125 and Pd-103
MJ Rivardl , BL Kirk
MEDICAL PHYSICS 30 ( 6) 1430 -1430
2003
Treatment of in-stent restenosis for saphenous vein grafts using intravascular brachytherapy: regulatory challenges and clinical application.
Carey D. Kimmelstiel , John E. Mignano , Heather D. Zinkin , Mark J. Rivard
Journal of Invasive Cardiology 16 ( 2) 96 -99
2
2004
Dosimetry for californium-252 (252Cf) neutron-emitting brachytherapy sources and encapsulation, storage, and clinical delivery thereof
Mark J. Rivard
23
2003
Plaque Therapy and Scatter Dose Using {sup 252}Cf Sources
Mark J. Rivard , Anita Mahajan
2000
A Phase I/II Protocol Using {sup 252}Cf for the Treatment of Cervical Carcinoma
David E. Wazer , Anita Mahajan , Evelyn R. Nunez , Mark J. Rivard
2000
Recommendations on the Practice of Calibration, Dosimetry, and Quality Assurance for Gamma Stereotactic Radiosurgery: Report of AAPM Task Group 178.
J. Daniel Bourland , Paula L. Petti , Almon S. Shiu , Sheridan G. Meltsner
Medical Physics
2021
Quantifying risk using FMEA: An alternate approach to AAPM TG-100 for scoring failures and evaluating clinical workflow.
Gene A. Cardarelli , David E. Wazer , Jaroslaw T. Hepel , James M. Brindle
Brachytherapy
2021
Simulation evaluation of NIST air-kerma rate calibration standard for electronic brachytherapy.
Jessica R. Hiatt , Mark J. Rivard , H. Grady Hughes
Medical Physics 43 ( 3) 1119 -1129
7
2016